| Financial Year |
March 31 2023 |
| Monetary Funds |
988,881,056.83 |
| Held-for-trading Financial Assets |
560,674,094.28 |
| Notes Receivable |
290,216,827.29 |
| Accounts Receivable |
3,256,534,774.19 |
| Advances to Suppliers |
186,719,336.25 |
| Other Receivables |
224,034,700.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,540,484,780.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,087,639.82 |
| Total Current Assets |
7,260,748,392.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
665,514,556.95 |
| Investment Properties |
38,523,495.44 |
| Fixed Assetes |
598,046,056.74 |
| Under-construction Projects |
553,103,547.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
503,300,789.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
638,663.37 |
| Deferred Income Tax Assets |
101,234,537.03 |
| Other Non-Current Assets |
101,610,117.00 |
| Sub-Total of Non-Current Assets |
2,609,916,970.21 |
| Total Assets |
9,870,665,362.51 |
| Short-Term Loans |
789,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,081,011.50 |
| Accounts Payable |
619,836,144.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,665,609.56 |
| Taxes Payable |
51,699,191.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
63,281,198.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
174,555,695.94 |
| Other Current Liabilities |
192,131,808.74 |
| Sub-Total of Current Liabilities |
2,357,600,444.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,409,253.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
149,221,118.17 |
| Total Liabilities |
2,506,821,562.32 |
| Paid-In Capital(Or Share Stock) |
3,326,796,000.00 |
| Capital Surplus |
190,398,327.51 |
| Surplus Reserve |
519,521,386.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,112,615,548.90 |
| Minority Stockholder's Interest |
135,388,491.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,228,455,309.13 |
| Owner's Equity（Stockholder's Equity） |
7,363,843,800.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,870,665,362.51 |
